ClinicalTrials.Veeva

Menu

Effectiveness of Probiotic Supplementation on Crying Time in Infantile Colic

B

BioGaia

Status

Withdrawn

Conditions

Colic, Infantile

Treatments

Dietary Supplement: Placebo
Dietary Supplement: Lactobacillus reuteri DSM17938

Study type

Interventional

Funder types

Industry

Identifiers

NCT03106285
CSUB0130

Details and patient eligibility

About

This study aims to investigate the effectiveness of Lactobacillus reuteri DSM17938 supplementation on infantile colic in Indonesian infants.

Full description

Infantile colic is a problem faced by many parents and caregivers. There is no evidence that medications does help in this situation. The etiology of infantile colic is still unknown.

Lactobacillus reuteri has been shown in five studies to reduce crying time in infants diagnosed with infantile colic.

Sex

All

Ages

Under 3 months old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • otherwise healthy infants
  • Infantile colic according to Roe IV criteria
  • Full term infants
  • Birth weight 2500 - 4000g
  • Exclusively breast milk or partially breastfed
  • Mothers last education degree is Senior high school

Exclusion Criteria

  • Clinically suspected allergy
  • Consumption of probiotics, antibiotics, PPI
  • Failure to thrive

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

0 participants in 2 patient groups, including a placebo group

Lactobacillus reuteri DSM17938
Experimental group
Description:
Oil drops
Treatment:
Dietary Supplement: Lactobacillus reuteri DSM17938
Placebo
Placebo Comparator group
Description:
Oils drops
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems